Group One Trading
NVO

Group One Trading’s Novo Nordisk NVO Stock Holding History

Group One Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Sell
63,042
-41,409
-40% -$1.78M ﹤0.01% 1833
2026
Q1 		$3.84M Buy
104,451
+54,177
+108% +$2.57M 0.01% 1516
2025
Q4 		$2.56M Sell
50,274
-128,309
-72% -$6.56M ﹤0.01% 2056
2025
Q3 		$9.91M Sell
178,583
-104,008
-37% -$6.09M 0.02% 906
2025
Q2 		$19.5M Sell
282,591
-22,804
-7% -$1.55M 0.04% 445
2025
Q1 		$21.2M Buy
305,395
+98,579
+48% +$8.14M 0.06% 300
2024
Q4 		$17.8M Buy
206,816
+119,453
+137% +$12.9M 0.04% 426
2024
Q3 		$10.4M Sell
87,363
-1,555
-2% -$207K 0.03% 601
2024
Q2 		$12.7M Buy
88,918
+593
+0.7% +$78.6K 0.05% 333
2024
Q1 		$11.3M Sell
88,325
-94,784
-52% -$11.3M 0.04% 392
2023
Q4 		$18.9M Buy
183,109
+112,999
+161% +$11.2M 0.05% 371
2023
Q3 		$6.38M Buy
70,110
+27,950
+66% +$2.46M 0.02% 785
2023
Q2 		$3.41M Buy
42,160
+23,552
+127% +$1.92M 0.01% 1264
2023
Q1 		$1.48M Buy
+18,608
New +$1.32M 0.01% 1788
2021
Q4 		– Sell
-39,850
Closed -$2.16M – 8651
2021
Q3 		$1.91M Sell
39,850
-47,186
-54% -$2.28M ﹤0.01% 2698
2021
Q2 		$3.65M Sell
87,036
-6,400
-7% -$248K ﹤0.01% 2009
2021
Q1 		$3.15M Buy
93,436
+81,160
+661% +$2.89M ﹤0.01% 1975
2020
Q4 		$429K Buy
12,276
+2,130
+21% +$73.6K ﹤0.01% 3407
2020
Q3 		$352K Sell
10,146
-33,222
-77% -$1.11M ﹤0.01% 3159
2020
Q2 		$1.42M Buy
43,368
+39,896
+1,149% +$1.27M 0.01% 1727
2020
Q1 		$105K Sell
3,472
-17,022
-83% -$507K ﹤0.01% 3260
2019
Q4 		$593K Buy
+20,494
New +$567K ﹤0.01% 2302
2019
Q2 		– Sell
-6,990
Closed -$173K – 5257
2019
Q1 		$183K Buy
+6,990
New +$172K ﹤0.01% 2771
2018
Q3 		– Sell
-11,660
Closed -$285K – 5485
2018
Q2 		$269K Buy
+11,660
New +$277K ﹤0.01% 2808
2017
Q3 		– Sell
-2,402
Closed -$54.3K – 5049
2017
Q2 		$52K Buy
+2,402
New +$48.5K ﹤0.01% 3493
2016
Q4 		– Sell
-45,194
Closed -$819K – 4698
2016
Q3 		$940K Buy
+45,194
New +$1.12M 0.01% 1321
2016
Q2 		– Sell
-2,242
Closed -$61.5K – 4839
2016
Q1 		$61K Buy
+2,242
New +$60.1K ﹤0.01% 3146
2015
Q3 		– Sell
-12,382
Closed -$351K – 5081
2015
Q2 		$339K Buy
12,382
+1,752
+16% +$49.3K ﹤0.01% 2124
2015
Q1 		$284K Buy
+10,630
New +$245K ﹤0.01% 2095
2014
Q3 		– Sell
-10,908
Closed -$251K – 5355
2014
Q2 		$252K Buy
10,908
+3,506
+47% +$77.4K ﹤0.01% 2191
2014
Q1 		$169K Sell
7,402
-28,828
-80% -$614K ﹤0.01% 2585
2013
Q4 		$669K Sell
36,230
-16,420
-31% -$286K 0.01% 1432
2013
Q3 		$891K Buy
52,650
+26,630
+102% +$448K 0.02% 1101
2013
Q2 		$403K Buy
+26,020
New +$433K 0.01% 1523

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Group One Trading's NVO Position: Q2 2026 in Review

Group One Trading reduced its Novo Nordisk (NVO) stake by 40% in Q2 2026, selling an estimated $1.78M and leaving 63,042 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Group One Trading first reported a position in NVO in Q2 2013 and has held it in 34 quarters since. The position peaked at $21.2M in Q1 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Group One Trading held 63,042 shares of Novo Nordisk worth $3.02M as of Q2 2026.
  • Group One Trading sold 41,409 Novo Nordisk shares in Q2 2026, an estimated $1.78M.
  • Novo Nordisk made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1833 holding.
  • Group One Trading first reported a position in Novo Nordisk in Q2 2013 and has held it in 34 quarters since.
  • Group One Trading's Novo Nordisk position peaked at $21.2M in Q1 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.